Higuchi John W. 4

What Happened

• John W. Higuchi, a director of Lipocine Inc. (LPCN), was granted a derivative award representing 1,764 shares on 2026-06-03. The award is reported at $2.19 per share for a total reported value of $3,863. This transaction is coded as an award/grant (A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-03; filing date: 2026-06-04 (filed the next day, within the normal 2-business-day Form 4 window).
• Price/value reported: $2.19 per share; total value $3,863.
• Securities acquired: derivative award for 1,764 shares (code A = award/grant).
• Vesting: 100% vests one year from the grant date (per footnote).
• Shares owned after the transaction: not specified in the provided filing excerpt.

Context

• This was a compensation-style award (derivative grant) that will vest in one year; such grants are typically part of director/executive compensation and do not represent an immediate open-market investment decision. The award becomes economically meaningful only upon vesting (and any subsequent conversion or sale).